The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Nutrition and ExerciseNutrition and Exercise
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary


Jun 23, 2008

Hi. Do you have any information on tnx-355. I've been waiting since Oct. 07; currently on Abacavir and Truv. T-cel (10) and Vl 35 thou. Dr. wants to put together tnx-355, prevista, and Isentress. Resistant to all but Prevista, abacavir, Videx. and Tramvir. What do you think?

Response from Mr. Vergel

The last time I spoke with TANOX three months ago, they still had plans to proceed with a phase III study of TNX 355. TANOX got bought out by Genentech and that slowed down the development process for TNX 355. TNX 355 is an IV HIV drug that may be used once every two weeks with a background of oral daily drugs.

Am I to assume that you have resistance to Fuzeon and also to Intelence (TMC 125)? Has your doctor done a tropism test to see if you are a candidate for Maraviroc? If not, you could start Isentress + Prezista (plus Norvir) + Truvada + Fuzeon or Maraviroc or Intelence.

My guess is that TNX 355 will not be available in expanded access for more than two years, so I would not wait if your CD4 cells are low.

Let me know if you need anything else. I follow salvage therapies closely since I am a salvage patient and also run


constant diahrrea

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint